SIA
NVAX icon

Sit Investment Associates’s Novavax NVAX Stock Holding History

Sit Investment Associates’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-8,275
Closed -$1.2M – 459
2016
Q2 		$1.2M Sell
8,275
-1,095
-12% -$125K 0.03% 291
2016
Q1 		$967K Hold
9,370
– – 0.02% 320
2015
Q4 		$1.57M Buy
9,370
+2,190
+31% +$337K 0.03% 268
2015
Q3 		$1.01M Buy
+7,180
New +$1.61M 0.02% 308

Other funds holding NVAX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Sit Investment Associates's NVAX Position: Q3 2016 in Review

Sit Investment Associates sold out of Novavax (NVAX) in Q3 2016, closing a stake of 8,275 shares — an estimated $1.2M sold.

Sit Investment Associates first reported a position in NVAX in Q3 2015 and held it in 4 quarters. The position peaked at $1.57M in Q4 2015. 165 funds tracked by Wall St. Rank hold NVAX as of Q3 2016.

  • Sit Investment Associates reported no remaining Novavax position as of Q3 2016 after selling out during the quarter.
  • Sit Investment Associates sold 8,275 Novavax shares in Q3 2016, an estimated $1.2M.
  • Sit Investment Associates first reported a position in Novavax in Q3 2015 and held it in 4 quarters.
  • Sit Investment Associates's Novavax position peaked at $1.57M in Q4 2015.
  • 165 funds tracked by Wall St. Rank held Novavax as of Q3 2016.

Based on Sit Investment Associates's 13F filing for Q3 2016, filed 1 Nov 2016.